You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 19, 2025

Drug Price Trends for BACITRACIN-POLYMYXIN EYE OINT


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for BACITRACIN-POLYMYXIN EYE OINT

Average Pharmacy Cost for BACITRACIN-POLYMYXIN EYE OINT

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
BACITRACIN-POLYMYXIN EYE OINT 24208-0555-55 2.44732 GM 2024-12-18
BACITRACIN-POLYMYXIN EYE OINT 24208-0555-55 2.02091 GM 2024-11-20
BACITRACIN-POLYMYXIN EYE OINT 24208-0555-55 2.91534 GM 2024-10-23
BACITRACIN-POLYMYXIN EYE OINT 24208-0555-55 3.14410 GM 2024-09-18
BACITRACIN-POLYMYXIN EYE OINT 24208-0555-55 2.73543 GM 2024-08-21
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Bacitracin-Polymyxin Eye Ointment

Introduction to Bacitracin-Polymyxin Eye Ointment

Bacitracin-Polymyxin eye ointment is a sterile antimicrobial ointment formulated for ophthalmic use. It combines bacitracin zinc and polymyxin B sulfate, making it effective against a wide range of bacterial infections affecting the eyes[1][5].

Clinical Pharmacology and Indications

The ointment is composed of bacitracin zinc, which is active against most gram-positive bacilli and cocci, including hemolytic streptococci. Polymyxin B sulfate targets gram-negative bacilli, including strains of Pseudomonas aeruginosa and Haemophilus influenzae[1].

It is indicated for the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by susceptible bacteria. These infections include conjunctivitis, keratitis, keratoconjunctivitis, blepharitis, and blepharoconjunctivitis[1][5].

Market Demand and Growth

The demand for ophthalmic anti-infectives, including bacitracin-polymyxin eye ointment, is influenced by several factors:

  • Increasing Screen Time and Digital Device Usage: The rise in screen time and digital device usage contributes to eye health issues, including dry eye and increased susceptibility to infections. This trend is expected to continue, driving the demand for ophthalmic treatments[3].
  • Rising Awareness and Diagnosis: Greater awareness and improved diagnostic techniques for eye infections are leading to more prescriptions for antimicrobial ointments like bacitracin-polymyxin.
  • Ophthalmic Innovations: Advances in ophthalmic treatments, including preservative-free formulations and combined therapy approaches, are enhancing the market for eye care products[3].

Market Size and Projections

While the specific market size for bacitracin-polymyxin eye ointment is not detailed, the broader ophthalmic anti-infectives market is part of the larger eye care products market. This market is projected to grow significantly:

  • The global dry eye products market, which includes ophthalmic anti-infectives, is expected to grow from $7.26 billion in 2023 to $7.74 billion in 2024, with a compound annual growth rate (CAGR) of 6.7%. By 2028, it is anticipated to reach $9.7 billion with a CAGR of 5.8%[3].

Pricing and Cost Considerations

The cost of bacitracin-polymyxin eye ointment can vary based on the pharmacy and the use of discount cards or patient assistance programs.

  • Current Pricing: A typical supply of 3.5 grams of bacitracin-polymyxin eye ointment can cost around $28 for cash-paying customers. This price can be reduced with the use of discount cards, such as the Drugs.com Discount Card, which can save up to 80% or more off the cost[2].
  • Price Variability: Prices can range from $27.72 for 3.5 grams, depending on the pharmacy and availability. For example, using a discount card, the price could be significantly lower[2].

Patient Assistance and Copay Programs

For patients who find the cost prohibitive, there are several options available:

  • Discount Cards: Cards like the Drugs.com Discount Card can offer substantial savings on prescription and over-the-counter medications.
  • Patient Assistance Programs (PAPs): Although no specific PAPs were found for bacitracin-polymyxin eye ointment, patients may be eligible for other programs through their healthcare providers or pharmaceutical companies[2].

Contraindications and Safety Considerations

It is crucial to note that bacitracin-polymyxin eye ointment is contraindicated in individuals who have shown hypersensitivity to any of its components. This highlights the importance of proper diagnosis and medical supervision before using the ointment[1][5].

Future Trends and Innovations

The ophthalmic market is expected to see several trends that could impact the demand and pricing of bacitracin-polymyxin eye ointment:

  • Advanced Treatment Modalities: New and more effective treatment options may emerge, potentially affecting the market share of existing products.
  • Preservative-Free Formulations: There is a growing preference for preservative-free ophthalmic products, which could influence the formulation and pricing of bacitracin-polymyxin eye ointment.
  • Integration with Wearable Tech: The integration of eye care with wearable technology could enhance patient compliance and monitoring, potentially increasing the demand for ophthalmic treatments[3].

Key Takeaways

  • Market Growth: The ophthalmic anti-infectives market, including bacitracin-polymyxin eye ointment, is expected to grow due to increased screen time, rising awareness, and ophthalmic innovations.
  • Pricing: The cost of bacitracin-polymyxin eye ointment varies but can be significantly reduced with discount cards and patient assistance programs.
  • Safety: The ointment is contraindicated in individuals with hypersensitivity to its components, emphasizing the need for medical supervision.
  • Future Trends: The market will be influenced by advanced treatment modalities, preservative-free formulations, and integration with wearable technology.

FAQs

Q: What is bacitracin-polymyxin eye ointment used for? A: Bacitracin-polymyxin eye ointment is used for the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by susceptible bacteria.

Q: How much does bacitracin-polymyxin eye ointment typically cost? A: The cost can range from around $28 for a 3.5-gram supply, but prices can be lower with the use of discount cards.

Q: Are there any patient assistance programs available for bacitracin-polymyxin eye ointment? A: While no specific programs were found, patients may be eligible for other assistance programs through their healthcare providers or pharmaceutical companies.

Q: What are the contraindications for using bacitracin-polymyxin eye ointment? A: The ointment is contraindicated in individuals who have shown hypersensitivity to any of its components.

Q: How is the market for ophthalmic anti-infectives expected to grow in the coming years? A: The market is expected to grow significantly, driven by factors such as increased screen time, rising awareness, and ophthalmic innovations, reaching $9.7 billion by 2028.

Sources

  1. Drugs.com: Bacitracin Polymyxin B: Package Insert / Prescribing Info.
  2. Drugs.com: Bacitracin / neomycin / polymyxin b ophthalmic prices.
  3. The Business Research Company: Global Dry Eye Products Market Report 2024.
  4. Drugs.com: Bacitracin/polymyxin b topical Prices, Coupons, Copay Cards & Patient Assistance.
  5. DailyMed: Label: BACITRACIN ZINC AND POLYMYXIN B SULFATE ointment.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.